You can buy or sell Scholar Rock and other stocks, options, ETFs, and crypto commission-free!
Scholar Rock Holding Corporation Common Stock, also called Scholar Rock, is a biopharmaceutical company, which engages in developing and commercializing drug products. The company focuses on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Read More Its product candidate includes SRK-015, a selective first-in-class inhibitor of the activation of the growth factor myostatin in skeletal muscle, into clinical development for the treatment of spinal muscular atrophy. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Markets InsiderMar 18
Scholar Rock Reports Full Year 2018 Financial Results and Highlights Business Progress
Initiated and Progressed Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers, Transitioning to a Clinical-Stage Company Presented Compelling Preclinical Data from the SRK-181 Cancer Immunotherapy Program at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting Announced Strategic Collaboration with Gilead Sciences to Discover and Develop Highly Specific Inhibitors of TGFβ activation for the Treatment of Fibrotic Diseases Completed Initial Public Offering Raising Approximately $86 milli...
Associated PressMar 6
Scholar Rock to Participate in Upcoming Investor Conferences
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play...
-$0.50 per share
-$0.43 per share